To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Plasmapheresis Market

Plasmapheresis Market Analysis Report By Product (Instruments, Disposables), By Technology (Membrane Filtration, Centrifugation), By Application (Therapeutic Plasmapheresis, Source Plasma Collection), By End-User, By Region - Global Insights 2022-2032

Analysis of Plasmapheresis market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Global Plasmapheresis Market Outlook

The global plasmapheresis market is evaluated at USD 1.3 Billion in 2022 and is forecast to outshine USD 2.6 Billion by 2032, mounting at a CAGR of 7.4% from 2022 to 2032.

Report Attributes

Details

Base Year Value (2021A)

USD 1.2 Billion

Estimated Year Value (2022E)

USD 1.3 Billion

Projected Year Value (2032F)

USD 2.6 Billion

Global Growth Rate (2022-2032)

 7.4%

North America Market Share in 2021

~34%

North America Growth Rate (2022-2032)

~8.1%

Collective Value Share (China, USA, Germany) 2022: Top 3 Countries

~59%

Top 5 Companies Market Share in 2021

~41%

Key Companies Profiled

  • Haemonetics Corporation
  • Asahi Kasei Kuraray Medical Co. Ltd.
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Kawasumi Laboratories Inc.
  • Kaneka Corporation
  • Other Key Players

The global plasmapheresis market is likely to be influenced by a range of macroeconomic and microeconomic factors. Growth in global healthcare spending, especially increasing emphasis on advanced healthcare treatment in the Asia Pacific and the Middle East, is likely to create growth opportunities for market players.

In addition to these factors, increasing awareness of the treatment options available for treating immune system disorders, most notably myasthenia gravis, Guillain-Barre syndrome, Lyell's syndrome, systemic lupus erythematosus, and thrombotic thrombocytopenic purpura are likely to fuel the growth of the market.

Advancement in plasmapheresis, combined with growing avenues of treatment such as veterinary healthcare are likely to shape the future direction of the market during the forecast period.

However, as per the Fact.MR’s recently published report, the global plasmapheresis industry is likely to gain nearly 79 BPS by over the 2022 & 2032. It accounts for almost 35.9% market share in the global autoimmune disease diagnosis market which is projected to experience 21.1% CAGR growth during the forecast years.

Don't Need a Global Report?

Save 40% on Country & Region specific reports

2017-2021 Global Plasmapheresis Market Outlook in Comparison to 2022-2032 Growth Forecast

The continuous increase in population, pollution, flu etc. has boosted autoimmune diseases among people. Due to this, the demand for various types of autoimmune disease treatments has been increased in double digits which has led to the plasmapheresis demand.

The demand for plasmapheresis increased by 4.6% CAGR and the market value reached at USD 1.2 billion by the end of 2021. Global plasmapheresis market has generated nearly USD 239 million in last half-decade.

Moreover, it is likely to provide an absolute $ opportunity of more than USD 1.3 billion. The global market is dominated by the North American plasmapheresis market which has offered an absolute dollar opportunity of around USD 80 million in the previous half-decade.

Fact.MR projects the plasmapheresis market is projected to eyewitness the growth of 7.4% CAGR over 2022 & 2032 in comparison to a CAGR of 4.6% with which it grew from 2017 and 2021.

Plasmapheresis Market

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Increase in the Prevalence of Autoimmune Diseases fueling Adoption:

Increasing prevalence of thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and diffuse alveolar hemorrhage due to Goodpasture syndrome, hyper viscosity syndrome, chronic inflammatory demyelinating polyneuropathy, and other autoimmune diseases is likely to provide an impetus to the growth of the plasmapheresis equipment market during the assessment period.

Moreover, increasing emphasis on boosting healthcare infrastructure, combined with higher degree of awareness among end-users is likely to promote the growth of the market during the assessment period.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Increasing Healthcare Spending Likely to Boost Adoption of Plasmapheresis Treatment

An increase in healthcare spending in many regions has given a boost to the adoption of plasmapheresis treatment across various end-use industries. Countries in the Asia Pacific and the Middle East and Africa (MEA) are revamping their healthcare infrastructure, which is likely to give a boost to the demand for advanced treatment procedures. These factors are likely to provide an impetus to the growth of the plasmapheresis market during the assessment period.

Growing Adoption in Veterinary Immunotherapy Likely to Create Growth Opportunities

Increasing adoption of plasmapheresis treatment in veterinary healthcare is likely to create an impetus to the demand for plasmapheresis instruments and disposables during the assessment period. The application of plasmapheresis in treating muscle weakness disorder myasthenia gravis is effective and has paved the way for future use of this treatment option in veterinary healthcare. The treatment has the potential to be used in a range of immune system disorders, and it can be an option when traditional drug therapy is not effective.

Concerns about Side Effects Continue to be a Challenge

The concerns about side effects continue to be a challenge for plasmapheresis market, with a fall in arterial blood pressure, arrhythmias, and temporarily elevated temperature and paresthesia’s being the common side effects.

Although the side effects of plasmapheresis are not very serious, they nevertheless can be a factor that can impede the adoption of this treatment module during the forecast period. A decline in the use of plasmapheresis as a treatment option can create challenges for market players during the assessment period.

Country-wise Insights

What is the Growth Scenario of India Plasmapheresis Markets?

Decades of economic development in South Asia & Oceania has meant that many countries in the region are now in a position to pay more emphasis on their healthcare sector. Expansion of the healthcare sector in the region is likely to boost demand for medical devices, which in turn will augur well for the growth of the plasmapheresis equipment market.

The demand for plasmapheresis is unceasingly growing from countries such as India, Australia, Nepal, etc. due to the rising autoimmune diseases. The plasmapheresis equipment market in Indian Market will also be influenced by the increasing middle class and growth in the percentage of the geriatric population.

Although the region presents a host of opportunities, market players have faced challenges in terms of heterogeneity in consumer demographics and complex regulatory procedures.

However, the Indian plasmapheresis market is expected to witness 6.3% CAGR growth over the assessment period. It holds a significant market share in the South Asia & Oceania plasmapheresis market. In addition, South Asia & Oceania is expected to lose 37 BPS and offer an absolute $ opportunity of ~USD 156 million in ten years.

What are the Growth Prospect of Chinese Plasmapheresis Market?

East Asian countries such as Japan, China, are some of the leading consumers of plasmapheresis due to which they are holding more than 1/5th of market share in the regional market. The regular advancements in technologies and reduction in costs are likely to boost the Chinese plasmapheresis market which will support to overall plasmapheresis market during 2022 &2032.

Plasmapheresis market forecast by Fact.MR

Category-wise Insights

Which product type is projected to be the extensive contributor over the valuation period in Plasmapheresis Market?

According to the Centers for Disease Control and Prevention (CDCP)’s recently published data, nearly 37.3 million US population, around 1 in 10 American, is suffering from diabetes. Additionally, nearly 96 million American adults have prediabetes, around 1 in 3 Americans. Plasmapheresis is used to treat numerous types of sickle cell diseases and neurotherapy. In these and other treatments, the majority of doctors prefer Instruments to achieve the highest success rate.

However, the instruments sub-segment of plasmapheresis product type is acquiring the largest market share. It is projected to continue its dominance in the assessment period with a CAGR of 5.4% and offers an absolute dollar opportunity of USD 826.2 million by the end of 2032.

Which plasmapheresis technology is expected to provide lucrative growth in Plasmapheresis Market?

The plasma filtering from whole blood can be accomplished via the use of semipermeable membranes or centrifugation. The centrifugation technology takes advantage of the different specific gravities intrinsic to various blood products, such as white blood cells (WBCs), red blood cells (RBCs) platelets, and plasma.

However, the instruments sub-segment of plasmapheresis technology accounts for nearly 2/3rd of the global market value share in the plasmapheresis market. It is anticipated to offer an absolute dollar opportunity of nearly ~USD 914 million by the end of the forecast period.

Competitive Landscape: Top Companies in Plasmapheresis Market

Prominent players in the global plasmapheresis market are largely focusing on R&D by coming up with innovative ideas to foster the growth of products and services in the coming ten years. Companies have adopted numerous strategies such as mergers & acquisitions, partnerships etc. to have dominance in the market.

Fact.MR has provided detailed information about price points of top providers of plasmapheresis market positioned across regions, sales growth, production capacity, and speculative technological expansion in the recently published report.

For instance:

  1. In April 2021, The Haemonetics Corporation has announced that the CSL Plasma, Ltd. will not renew the supply agreement of PCS2 Plasma Collection System devices use and disposable plasmapheresis kits purchase in the United States
  2. In March 2022, CSL Plasma, Ltd. received FDA clearance for Rika Plasma Donation System which was developed by Cell Technologies and Terumo Blood

Global Plasmapheresis Market by Category

  • By Product, Global Plasmapheresis Market is segmented as:

    • Instruments
    • Disposables
  • By Technology, Global Plasmapheresis Market is segmented as:

    • Membrane Filtration
    • Centrifugation
  • By End-User, Global Plasmapheresis Market is segmented as:

    • Biopharmaceutical
    • Companies, Hospitals & Clinics
    • Other End Users
  • By Application, Global Plasmapheresis Market is segmented as:

    • Therapeutic Plasmapheresis
    • Source Plasma Collection
  • By Region, Global Plasmapheresis Market is segmented as:

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

- Premium Report Details -

Plasmapheresis Market
  • FACT351MR
  • Apr-2022
  • Healthcare
  • 170 Pages
  • 70 Tables
  • 114 Figures

- Let's Connect -

Talk To an Expert Today Connect

- Get Started -

Get insights that lead to new growth opportunities

Buy Now

Get A Special pricing for start-ups and universities

Enquiry Before Buying

- Humble, Yet Honored -

Our prestigious clients

- Research Methodology -

An Adaptive Approach to Modern-day Research Needs

Get Methodology

- FAQs -

The global value of plasmapheresis market is estimated to be worth over USD 1.3 Billion in 2022.

The demand is anticipated to surpass USD 2.6 Billion by 2032 end.

During 2017-2021, global plasmapheresis market grew at 4.6% CAGR.

Some of the prominent players in plasmapheresis market are Haemonetics Corporation, Asahi Kasei Kuraray Medical, Terumo Corporation, B. Braun Melsungen AG etc.

North America tops the global plasmapheresis market accounting for 1/3rd of global market share in 2022.

Instruments sub-segment contributes by holding 2/3rd of market share in global consumption of plasmapheresis.

Exclusive Report

Need An Exclusive Report For Your Unique Requirement?

Google translate